5-(4-amino-3-methylpiperidin-1-yl)-4-chloro-2-(2,2,2-trifluoroethyl)pyridazin-3-one
C12H16ClF3N4O — CID 114446413
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(4-amino-3-methylpiperidin-1-yl)-4-chloro-2-(2,2,2-trifluoroethyl)pyridazin-3-one
5-(4-amino-3-methylpiperidin-1-yl)-4-chloro-2-(2,2,2-trifluoroethyl)pyridazin-3-one (PubChem CID 114446413) has the molecular formula C12H16ClF3N4O and a molecular weight of 324.73 g/mol. Its IUPAC name is 5-(4-amino-3-methylpiperidin-1-yl)-4-chloro-2-(2,2,2-trifluoroethyl)pyridazin-3-one.
Molecular Properties
| Compound Name | 5-(4-amino-3-methylpiperidin-1-yl)-4-chloro-2-(2,2,2-trifluoroethyl)pyridazin-3-one |
|---|---|
| PubChem CID | 114446413 |
| Molecular Formula | C12H16ClF3N4O |
| Molecular Weight | 324.73 g/mol |
| Exact Mass | 324.10 |
| IUPAC Name | 5-(4-amino-3-methylpiperidin-1-yl)-4-chloro-2-(2,2,2-trifluoroethyl)pyridazin-3-one |
| SMILES | CC1CN(c2cnn(CC(F)(F)F)c(=O)c2Cl)CCC1N |
| InChI | InChI=1S/C12H16ClF3N4O/c1-7-5-19(3-2-8(7)17)9-4-18-20(6-12(14,15)16)11(21)10(9)13/h4,7-8H,2-3,5-6,17H2,1H3 |
| InChIKey | AGRRWUHDGMOYKM-UHFFFAOYSA-N |
| XLogP | 1.63 |
| TPSA | 64.15 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 324.73 |
| LogP ≤ 5 | 1.63 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 114446413 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.